Handelsavisen
prelaunch
Companies Healthcare 6029.T
60
6029.T Tokyo Stock Exchange Healthcare Facilities & Services

Artra Group Corp

¥177,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,8B JPY
P/E
8,4x
EV / Rev
0,6x
Div yield
0,00 %
Op margin
-3,0 %
ROE
-2,5 %
Net margin
-3,3 %
Debt / equity
1,02
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Artra Group Corp is a Japanese biotechnology company that provides healthcare services and equipment, primarily operating in the healthcare facilities and services industry.

Business. Artra Group Corp (6029.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
8,4x
P/E
Analysts
not yet wired
Ownership
not yet wired
Profitability
-2,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 6029.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 6029.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Artra Group Corp (6029.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    Artra Group Corp has a market price of 211 JPY per share, with a market capitalization of 2,166,280,874 JPY. The company's price-to-book ratio is 1.53, and its price-to-tangible-book ratio is also 1.53, indicating that the market values the company slightly above its book value. The enterprise value to EBITDA ratio is negative at -77.81, reflecting the company's current operating losses. The enterprise value to revenue ratio is 2.36, suggesting that the company is valued at a moderate multiple of its revenue.

    The company's profitability metrics are weak, with a return on equity of -2.47% and a return on assets of -0.83%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income is negative at -31,649,000 JPY, and the net income is also negative at -34,900,000 JPY. The company's debt-to-equity ratio is 1.02, suggesting that it is financed almost equally by debt and equity. The current ratio of 1.88 indicates that the company has sufficient current assets to cover its current liabilities.

    Artra Group Corp's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's total revenue for the period is 1,043,350,000 JPY, with a gross profit of 320,813,000 JPY. The company's operating and net losses suggest that it is not currently profitable and may be facing challenges in its core operations.

    The company's growth trajectory is uncertain, with no disclosed revenue growth or expansion plans. The company's operating and net losses indicate that it is not currently generating positive cash flows from operations. The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations.

    The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may face liquidity challenges in the near term. The company's operating and net losses indicate that it is not currently profitable and may need to raise additional capital to fund its operations. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations.

    The company's recent financial performance, as reported in its latest financial statements, shows a revenue of 1,043,350,000 JPY and a gross profit of 320,813,000 JPY. The company's operating income is negative at -31,649,000 JPY, and its net income is also negative at -34,900,000 JPY. The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations.

    Key takeaways
    • Artra Group Corp is currently unprofitable, with a negative return on equity and return on assets.
    • The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt.
    • The company's debt-to-equity ratio is 1.02, indicating a significant reliance on debt financing.
    • The company's enterprise value to EBITDA ratio is negative, reflecting its current operating losses.
    • The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
    • The company's risk assessment indicates a medium liquidity risk and a low dilution risk.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Net income surged 803.1% year-over-year to JPY 258 million in FY2026, signaling a strong profitability turnaround.

    Free cash flow improved dramatically by 629.9% to JPY 285.5 million in FY2026, enhancing liquidity and financial flexibility.

    Long-term debt decreased steadily from JPY 2.44 billion in FY2022 to JPY 1.06 billion in FY2026, reducing leverage.

    Operating income jumped 643.4% year-over-year to JPY 139.3 million in FY2026, demonstrating significant operational efficiency gains.

    Revenue maintained a positive 5.6% CAGR over four years, indicating consistent top-line growth despite recent quarterly declines.

    BEAR CASE · 2

    The company faces high credit risk, posing a significant threat to its financial stability and borrowing costs.

    Debt-to-equity ratio of 1.02 is in the bottom quartile versus peers, indicating excessive leverage relative to the sector.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-13
    Q4 2025 · Quarter highlights

    Revenue ¥1.10B, −4,5% YoY; Operating income +17,8% YoY.

    Revenue¥1.10B−4,5 % YoY
    Operating income¥51.9M+17,8 % YoY
    Net income¥79.4M+91,2 % YoY
    Free cash flow
    EPS
    Operating cash flow¥275.2M+37,0 % YoY
    Financials
    Income statement
    Revenue¥1.10B
    Gross profit¥356.5M
    Operating income¥51.9M
    Net income¥79.4M
    Margins
    Gross margin32.4%
    Operating margin4.7%
    Net margin7.2%
    FCF margin
    Balance sheet
    Total assets¥4.13B
    Total liabilities¥2.43B
    Total equity¥1.70B
    Cash & equivalents¥1.13B
    Long-term debt¥1.06B
    Cash flow
    Operating cash flow¥275.2M
    CapEx-¥78.2M
    Free cash flow
    SBC
    P&L flow · revenue → net income
    Revenue ¥1.10BOperating costs ¥1.05BNet income ¥79.4M
    Highlights
    • Revenue ¥1.10B, −4,5% YoY
    • Operating income +17,8% YoY
    • Net income +91,2% YoY
    • Net margin 7.2%

    Valuation TTM

    Market price
    ¥177,00
    Market cap
    ¥2.17B
    Enterprise value
    ¥2.46B
    P/E
    8.4x
    Non-GAAP P/E
    EV / Revenue
    0.6x
    EV / Op income
    17.7x
    EV / OCF
    P / B
    1.5x
    P / Tangible book
    1.5x
    Tangible book
    ¥1.41B
    Net cash
    -¥296.2M
    Current ratio
    1.9
    Debt / equity
    1.0
    ROA
    -0.8%
    ROE
    -2.5%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-3,0 %Below median
    Net Margin-3,3 %Below median
    ROE-2,5 %Bottom quartile
    D/E1,02Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    • Ev To Revenue
      enterprise_value / revenue
    Source documents
    • Artra Group Corp Market data — financials · 2026-05-27
    • Artra Group Corp Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    6029.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-02-13 11:55 UTCEARNINGSQuarterly results — Q4 2025 Revenue JPY 1.10B · Net JPY 79.4M
    2026-02-13 11:55 UTCEARNINGSAnnual results — FY 2026 Revenue JPY 3.93B · Net JPY 258.3M
    2025-11-14 12:00 UTCEARNINGSQuarterly results — Q3 2025 Revenue JPY 944.5M · Net JPY 63.3M
    2025-08-08 11:41 UTCEARNINGSQuarterly results — Q2 2025 Revenue JPY 903.7M · Net JPY 135.3M
    2025-05-15 11:30 UTCEARNINGSQuarterly results — Q1 2025 Revenue JPY 979.7M · Net JPY -19.7M
    2025-02-14 12:00 UTCEARNINGSQuarterly results — Q4 2024 Revenue JPY 1.15B · Net JPY 41.5M
    2025-02-14 12:00 UTCEARNINGSAnnual results — FY 2025 Revenue JPY 4.23B · Net JPY -36.7M
    2024-11-13 12:00 UTCEARNINGSQuarterly results — Q3 2024 Revenue JPY 1.03B · Net JPY -14.6M
    2024-08-08 12:00 UTCEARNINGSQuarterly results — Q2 2024 Revenue JPY 1.01B · Net JPY -28.7M
    2024-05-14 12:00 UTCEARNINGSQuarterly results — Q1 2024 Revenue JPY 1.04B · Net JPY -34.9M
    2024-02-14 12:00 UTCEARNINGSAnnual results — FY 2024 Revenue JPY 4.50B · Net JPY 54.0M
    2023-02-14 12:00 UTCEARNINGSAnnual results — FY 2023 Revenue JPY 4.67B · Net JPY 2.1M
    2022-02-18 13:30 UTCEARNINGSAnnual results — FY 2022 Revenue JPY 3.16B · Net JPY -351.1M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage